External quality assessment for the molecular detection of microsatellite instability in China, 2021-2022

References

• Hause RJ, Pritchard CC, Shendure J, et al. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22(11):1342–1350. doi: 10.1038/nm.4191
   PubMed Web of Science ®Google Scholar
• Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260(5109):812–816. doi: 10.1126/science.8484121
   PubMed Web of Science ®Google Scholar
• Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409–413. doi: 10.1126/science.aan6733
   PubMed Web of Science ®Google Scholar
• Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247–257. doi: 10.1056/NEJMoa022289
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–1422. doi: 10.1093/annonc/mdw235
   PubMed Web of Science ®Google Scholar
• Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993;260(5109):816–819. doi: 10.1126/science.8484122
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–359. doi: 10.6004/jnccn.2021.0012
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: rectal cancer, version 6.2020. J Natl Compr Canc Netw. 2020;18(7):806–815. doi: 10.6004/jnccn.2020.0032
   PubMed Web of Science ®Google Scholar
• Luchini C, Bibeau F, Ligtenberg MJL, et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol. 2019;30(8):1232–1243. doi: 10.1093/annonc/mdz116
   PubMed Web of Science ®Google Scholar
• Nowak JA, Yurgelun MB, Bruce JL, et al. Detection of mismatch repair deficiency and microsatellite instability in colorectal adenocarcinoma by targeted next-generation sequencing. J Mol Diagn. 2017;19(1):84–91. doi: 10.1016/j.jmoldx.2016.07.010
   PubMed Web of Science ®Google Scholar
• D’Asnieres De Salins A G, Tachon G, Cohen R, et al. Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer. ESMO Open. 2021;6(3):100120. doi: 10.1016/j.esmoop.2021.100120
   PubMed Web of Science ®Google Scholar
• Wang F, Zhao Q, Wang YN, et al. Evaluation of POLE and POLD1 mutations as biomarkers for immunotherapy outcomes across multiple cancer types. JAMA Oncol. 2019;5(10):1504–1506. doi: 10.1001/jamaoncol.2019.2963
   PubMed Web of Science ®Google Scholar
• Pal A, Greenblatt HM, Levy Y. Prerecognition diffusion mechanism of human DNA mismatch repair proteins along DNA: Msh2-Msh3 versus Msh2-Msh6. Biochemistry. 2020;59(51):4822–4832. doi: 10.1021/acs.biochem.0c00669
   PubMed Web of Science ®Google Scholar
• You JF, Buhard O, Ligtenberg MJ, et al. Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats. Br J Cancer. 2010;103(12):1840–1845. doi: 10.1038/sj.bjc.6605988
   PubMed Web of Science ®Google Scholar
• Harada S, Morlote D. Molecular pathology of colorectal cancer. Adv Anat Pathol. 2020;27(1):20–26. doi: 10.1097/PAP.0000000000000247
   PubMed Web of Science ®Google Scholar
• Trabucco SE, Gowen K, Maund SL, et al. A novel next-generation sequencing approach to detecting microsatellite instability and pan-tumor characterization of 1000 microsatellite instability-high cases in 67,000 patient samples. J Mol Diagn. 2019;21(6):1053–1066. doi: 10.1016/j.jmoldx.2019.06.011
   PubMed Web of Science ®Google Scholar
• Toh JWT, Singh P, Tangirala V, et al. A simple, accurate and cost-effective capillary electrophoresis test with computational methods to aid in universal microsatellite instability testing. Cells. 2021;10(6):1401. doi: 10.3390/cells10061401
   PubMed Web of Science ®Google Scholar
• Li K, Luo H, Huang L, et al. Microsatellite instability: a review of what the oncologist should know. Cancer Cell Int. 2020;20(1):16. doi: 10.1186/s12935-019-1091-8
   PubMed Web of Science ®Google Scholar
• Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10(4):293–300. doi: 10.2353/jmoldx.2008.080031
   PubMed Web of Science ®Google Scholar
• Boland CR, Thibodeau SN, Hamilton SR, et al. A National cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248–5257. PMID: 9823339.
   PubMed Web of Science ®Google Scholar
• Terdiman JP, Gum Jr. JR, Conrad PG, et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology. 2001;120(1):21–30. doi: 10.1053/gast.2001.20874
   PubMed Web of Science ®Google Scholar
• Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96(4):261–268. doi: 10.1093/jnci/djh034
   PubMed Web of Science ®Google Scholar
• Bacher JW, Flanagan LA, Smalley RL, et al. Development of a fluorescent multiplex assay for detection of MSI-High tumors. Dis Markers. 2004;20(4–5):237–250. doi: 10.1155/2004/136734
   PubMed Web of Science ®Google Scholar
• Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7(3):153–162. doi: 10.1038/nrclinonc.2009.237
   PubMed Web of Science ®Google Scholar
• Engel KB, Moore HM. Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med. 2011;135(5):537–543. doi: 10.5858/2010-0702-RAIR.1
   PubMed Web of Science ®Google Scholar
• Sarode VR, Robinson L. Screening for Lynch syndrome by immunohistochemistry of mismatch repair proteins: significance of indeterminate result and correlation with mutational studies. Arch Pathol Lab Med. 2019;143(10):1225–1233. doi: 10.5858/arpa.2018-0201-OA
   PubMed Web of Science ®Google Scholar
• Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(20):3219–3226. doi: 10.1200/JCO.2009.27.1825
   PubMed Web of Science ®Google Scholar
• Dancey JE, Bedard PL, Onetto N, et al. The genetic basis for cancer treatment decisions. Cell. 2012;148(3):409–420. doi: 10.1016/j.cell.2012.01.014
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang R, Han Y, et al. Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection. Diagn Pathol. 2016;11(1):85. doi: 10.1186/s13000-016-0537-8
   PubMedGoogle Scholar
• Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883–892. doi: 10.1056/NEJMoa1113205
   PubMed Web of Science ®Google Scholar
• van Krieken JH, Siebers AG, Normanno N, et al. European consensus conference for external quality assessment in molecular pathology. Ann Oncol. 2013;24(8):1958–1963. doi: 10.1093/annonc/mdt153
   PubMed Web of Science ®Google Scholar
• Deans ZC, Bilbe N, O’Sullivan B, et al. Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment. J Clin Pathol. 2013;66(4):319–325. doi: 10.1136/jclinpath-2012-201227
   PubMed Web of Science ®Google Scholar
• Greub G, Sahli R, Brouillet R, et al. Ten Years of R&D and full automation in molecular diagnosis. Future Microbiol. 2016;11(3):403–425. doi: 10.2217/fmb.15.152
   PubMed Web of Science ®Google Scholar
• Patton S, Normanno N, Blackhall F, et al. Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. Br J Cancer. 2014;111(2):413–420. doi: 10.1038/bjc.2014.353
   PubMed Web of Science ®Google Scholar
• Loh TP, Sandberg S, Horvath AR. Lot-to-lot reagent verification: challenges and possible solutions. Clin Chem Lab Med. 2022;60(5):675–680. doi: 10.1515/cclm-2022-0092
   PubMed Web of Science ®Google Scholar
• Aarsand AK, Villanger JH, Stole E, et al. European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clin Chem. 2011;57(11):1514–1523. doi: 10.1373/clinchem.2011.170357
   PubMed Web of Science ®Google Scholar